Barclays PLC lessened its holdings in shares of NICE Ltd. (NASDAQ:NICE - Free Report) by 100.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 748 shares of the technology company's stock after selling 6,915,558 shares during the period. Barclays PLC's holdings in NICE were worth $130,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Creative Financial Designs Inc. ADV boosted its holdings in NICE by 208.3% in the third quarter. Creative Financial Designs Inc. ADV now owns 148 shares of the technology company's stock worth $26,000 after acquiring an additional 100 shares in the last quarter. ORG Wealth Partners LLC bought a new position in NICE in the 3rd quarter worth about $38,000. GAMMA Investing LLC boosted its stake in NICE by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 245 shares of the technology company's stock worth $43,000 after purchasing an additional 116 shares in the last quarter. Allspring Global Investments Holdings LLC grew its position in NICE by 48.9% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 277 shares of the technology company's stock valued at $48,000 after purchasing an additional 91 shares during the last quarter. Finally, Castleview Partners LLC bought a new stake in NICE during the 3rd quarter valued at about $88,000. 63.34% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts have recently issued reports on NICE shares. Royal Bank of Canada reiterated an "outperform" rating and issued a $260.00 target price on shares of NICE in a research note on Friday, November 15th. Jefferies Financial Group reiterated a "hold" rating and set a $200.00 target price (down from $215.00) on shares of NICE in a research note on Thursday, December 19th. Piper Sandler restated a "neutral" rating on shares of NICE in a research note on Thursday, November 14th. Northland Securities dropped their price objective on NICE from $275.00 to $250.00 and set an "outperform" rating on the stock in a research report on Friday, November 15th. Finally, Oppenheimer lowered NICE from an "outperform" rating to a "market perform" rating in a research report on Friday, November 15th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $259.50.
Check Out Our Latest Report on NICE
NICE Trading Down 0.4 %
NASDAQ NICE traded down $0.61 on Thursday, hitting $165.72. 308,289 shares of the company traded hands, compared to its average volume of 300,418. The business's 50 day moving average price is $178.97 and its 200-day moving average price is $174.30. NICE Ltd. has a 52-week low of $151.52 and a 52-week high of $270.73. The company has a market capitalization of $10.42 billion, a price-to-earnings ratio of 25.65, a P/E/G ratio of 1.46 and a beta of 1.06.
NICE Profile
(
Free Report)
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
Featured Stories
Before you consider NICE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NICE wasn't on the list.
While NICE currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.